Genesis Hospice 2546 Tech Drive, Bettendorf, IA, 52722 | |
(563) 421-5100 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.
News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.
› Verified 9 days ago
Name | Genesis Hospice |
---|---|
Location | 2546 Tech Drive, Bettendorf, Iowa |
Hospice ID | 161520 |
Category | Part of a Home Health Agency |
Ownership Type | Voluntary Non-profit - Private |
Profit Type | NON-PROFIT |
SSA county code | 810 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.
News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.
› Verified 9 days ago
NPI Number | 1013968262 |
Organization Name | Genesis Health System |
Address | 2535 Maplecrest Rd Bettendorf, Iowa, 52722 |
Phone Number | (563)421-5400 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.
News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.
› Verified 9 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 90.1 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 84.8 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 89.7 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 97.5 | 97.3 |
Patients who got timely treatment for shortness of breath | 94.6 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 90.6 | 93.3 |
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.
News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.
› Verified 9 days ago
Home Health Aides | 10.7 |
Counselors | 6.9 |
Homemakers | 2.6 |
Licensed Practical or Vocational Nurses | 8.9 |
Medical Social Workers | 5.1 |
Physicians | 0.8 |
Registered Nurses | 36.5 |
Other Personnel | 15.6 |
Total Employees | 87.1 |
---|
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.
News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.
› Verified 9 days ago
Others | 2.37 |
Total Volunteers | 2.37 |
---|
News Archive
AstraZeneca today announced the results of the phase II studies, ONSET/OFFSET and RESPOND for ticagrelor (BRILINTA(TM)) at the annual American Heart Association (AHA) Scientific Sessions in Orlando, FL,with ONSET/OFFSET study results being simultaneously published in the medical journal Circulation.
Over the last years, many low and middle-income countries have removed user fees in their health care sector. Researchers from Africa, Asia, Northern America and Europe have studied these policies; their findings are gathered in a supplement of the scientific journal Health Policy & Planning, coordinated by Bruno Meesen from the Antwerp Institute of Tropical medicine.
According to the editor of the scientific journal Nature, Dr Philip Campbell current procedures to assess and censor medical research potentially of use to terrorists need to be improved. He was speaking about the recent controversy regarding the bird flu virus H5N1 study. The study was initially stopped from publication fearing risk of bioterrorism. He was speaking to BBC News.
News outlets began 2012 by looking ahead at what is promising to be a busy health care year, especially because of the 2010 federal health law.
› Verified 9 days ago
Genesis Hospice Location: 2546 Tech Drive, Bettendorf, Iowa, 52722 Phone: (563) 421-5100 |